Suppr超能文献

血容量对接受促红细胞生成素治疗的透析前及腹膜透析患者血压的影响。

Influence of blood volume on the blood pressure of predialysis and peritoneal dialysis patients treated with erythropoietin.

作者信息

Anastassiades E, Howarth D, Howarth J, Shanks D, Waters H, Hyde K, Yin J L, Geary C, Gokal R

机构信息

Department of Renal Medicine, Manchester Royal Infirmary, UK.

出版信息

Nephrol Dial Transplant. 1993;8(7):621-5.

PMID:8396746
Abstract

Twenty-seven patients with renal failure (16 on CAPD and 11 predialysis) were treated with erythropoietin. At 12 weeks, the mean haemoglobin concentration (+/- SEM) in the CAPD patients had increased from 7.07 +/- 0.20 to 10.88 +/- 0.45 g/dl (two-tailed paired t test, P < 0.0001) and in the predialysis patients from 6.90 +/- 0.35 to 10.05 +/- 0.47 g/dl (P < 0.0001). Predialysis patients were taking more antihypertensive medication at baseline. No increase was required in either group after erythropoietin; there was no change in blood pressure in the CAPD patients, though in the predialysis patients the systolic blood pressure rose slightly from 132 to 146 mmHg (P = 0.029) and the mean blood pressure from 95 to 103 mmHg (P = 0.028). In 12 patients (6 on CAPD and 6 predialysis) the red cell volume, plasma volume, and total blood volume were measured before and after treatment. In the CAPD patients there was a marked expansion of the red cell volume from 912 +/- 127 to 1471 +/- 222 ml (P = 0.004) and a concomitant contraction of the plasma volume from 3932 +/- 250 to 3178 +/- 326 ml (P = 0.005), leaving the blood volume unchanged from 4843 +/- 352 to 4649 +/- 503 ml. Predialysis patients had a similar expansion of the red cell volume from 733 +/- 59 to 1304 +/- 161 ml (P = 0.017) but no contraction of the plasma volume (from 3417 +/- 354 to 3314 +/- 260 ml), so that the blood volume tended to expand from 4149 +/- 347 to 4618 +/- 414 ml (P = 0.053).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

27例肾衰竭患者(16例接受持续性非卧床腹膜透析,11例处于透析前阶段)接受了促红细胞生成素治疗。12周时,持续性非卧床腹膜透析患者的平均血红蛋白浓度(±标准误)从7.07±0.20g/dl增至10.88±0.45g/dl(双侧配对t检验,P<0.0001),透析前患者的平均血红蛋白浓度从6.90±0.35g/dl增至10.05±0.47g/dl(P<0.0001)。透析前患者在基线时服用更多的抗高血压药物。促红细胞生成素治疗后两组均无需增加药物剂量;持续性非卧床腹膜透析患者的血压无变化,而透析前患者的收缩压从132mmHg轻度升至146mmHg(P=0.029),平均血压从95mmHg升至103mmHg(P=0.028)。对12例患者(6例持续性非卧床腹膜透析患者和6例透析前患者)在治疗前后测量了红细胞体积、血浆体积和总血容量。持续性非卧床腹膜透析患者的红细胞体积从912±127ml显著增至1471±222ml(P=0.004),同时血浆体积从3932±250ml收缩至3178±326ml(P=0.005),血容量从4843±352ml至4649±503ml无变化。透析前患者的红细胞体积从733±59ml有类似的增加至1304±161ml(P=0.017),但血浆体积无收缩(从3417±354ml至3314±260ml),因此血容量倾向于从4149±347ml增至4618±414ml(P=0.053)。(摘要截短于250词)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验